Exclusivity Extension News Today

Symbio Holdings Limited (ASX:SYM) refers to its announcement on 29 September 2023 advising the receipt of a non-binding indicative conditional proposal from Aussie Broadband Limited (ASX:ABB).

As antibiotic resistance increases globally, antibiotic innovation is struggling. WHO states that the antibiotic clinical pipeline is “insufficient to tackle the challenge of increasing emergence and spread of antimicrobial resistance”.1 To prevent the development of resistance, new antibiotics are used as last resort treatments and, if properly used, have small patient populations, resulting in fairly low sales revenues for industry.